PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Year Ending	TTM	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019
Cash & Equivalents	61.21	68.04	85.4	2.2	0.89	0.52
Cash & Cash Equivalents	61.21	68.04	85.4	2.2	0.89	0.52
Cash Growth	-15.73%	-20.33%	3778.14%	146.08%	73.67%	-51.38%
Other Current Assets	0.3	0.11	0.09	0.07	0.14	0.14
Total Current Assets	61.51	68.15	85.49	2.28	1.04	0.65
Long-Term Investments	3.58	1.57	1.57	1.57	1.57	1.57
Goodwill and Intangibles	3.55	3.55	3.55	3.55	3.55	3.55
Other Long-Term Assets	2.72	0.01	0.01	0.01	0.01	0.01
Total Long-Term Assets	9.85	5.13	5.13	5.13	5.13	5.13
Total Assets	71.36	73.28	90.62	7.4	6.17	5.78
Accounts Payable	0.48	0.13	0.21	0.17	0.19	0.12
Current Debt	0	0	0	0	0.03	0
Other Current Liabilities	7.05	0.46	0.5	0.55	0.82	0.62
Total Current Liabilities	7.54	0.59	0.7	0.72	1.03	0.74
Long-Term Debt	0	0	0	0	0.05	0
Other Long-Term Liabilities	14.93	0	0	0	0	0
Total Long-Term Liabilities	14.93	0	0	0	0.05	0
Total Liabilities	22.47	0.59	0.7	0.72	1.08	0.74
Total Debt	0	0	0	0	0.08	0
Retained Earnings	-116.97	-115.96	-111.65	-107.41	-103.86	-100.03
Comprehensive Income	-0.02	-0.02	-0.02	-0.02	-0.02	-0.01
Shareholders' Equity	31.37	72.69	89.92	6.68	5.09	5.04
Net Cash / Debt	61.21	68.04	85.4	2.2	0.82	0.52
Net Cash / Debt Growth	-15.73%	-20.33%	3778.14%	168.66%	59.08%	-51.38%
Net Cash Per Share	7.11	3.49	5.50	1.52	0.91	0.70
Working Capital	53.97	67.56	84.79	1.55	0.01	-0.09
Book Value Per Share	3.65	3.73	5.79	4.61	5.63	6.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).